iNetworks announced today an initial milestone investment in INDIGO Biosciences, Inc., State College, PA. INDIGO Biosciences, a leader in cell-based nuclear receptor assay products and services, serves the worldwide pharmaceutical industry from its State College facility. iNetworks was instrumental in the hiring of the new CEO of INDIGO, Mr. Fred Maroni and will enable further
Trust the nuclear receptor experts – KNOW INDIGO
INDIGO Biosciences is the only contract research services company focused exclusively on nuclear receptor screening.
Tools and Service for Pharmaceutical, Biotechnology, Chemical, Nutraceutical, Environmental, Food and Agriculture Research